[Treatment of chronic heart failure].
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002908:Chronic Disease; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006329:Heart Conduction System / Q000187:drug effects; D006333:Heart Failure / Q000145:classification / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D008722:Methods
D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D004232:Diuretics; D005934:Glucagon
Die Behandlung des chronischen Herzversagens